Community Pharmacy Assisting in Total Cardiovascular Health

Status

UNKNOWN

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT01509014

Acronym

CPATCH

Enrollment

2250

Registered

2012-01-12

Start date

2010-03-31

Completion date

2012-01-31

Last updated

2012-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adherence, Statin Therapy

Keywords

Statins, Adherence, Pharmacists

Brief summary

Despite proven benefits in reducing morbidity and mortality, many patients become nonadherent to statin therapy within the first year of starting. Due to their accessibility and frequent patient contact, pharmacists are well-positioned to improve medication adherence. The purpose of this study is to determine whether a simple intervention by community pharmacists can improve statin adherence in new statin users.

Interventions

BEHAVIORALCPATCH intervention to support statin adherence

Routine identification of new statin users (first year of therapy), consistent assessment of barriers to adherence at every dispensation for these patients, reassurance about efficacy and safety, and proactive response to identified adherence barriers.

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

HEALTH_SERVICES_RESEARCH

Masking

NONE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

* Pharmacies must fill at least 85 statin prescriptions in a six-week period * CPATCH intervention was given priority over other study initiatives offered by the pharmacy * All members of pharmacy staff provided informed consent

Design outcomes

Primary

Measure	Time frame	Description
Mean statin adherence among all eligible new users of statin medications with at least 6 months of follow-up from index prescription	6 months	All statin dispensations are captured by the prescription drug plan database. Mean adherence will be measured using the proportion of days covered (sum of days supply for statin prescriptions during study period divided by the number of days of observation). PDC will be adjusted for any days subject was hospitalized during study period.,

Secondary

Measure	Time frame
Proportion of new statin users with adherence greater than or equal to 80%	6 months
Persistence with statin use among patients with a minimum of 12 months of follow-up	6 months

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026